A Single-Center Clinical Study to Evaluate the Efficacy and Safety of Sutureless Ophthalmic Hydrogel for Corneal Wound Repair
調査の概要
状態
状態
条件
条件
介入・治療
介入・治療
研究の種類
研究の種類
入学 (推定)
入学
段階
段階
- 適用できない
連絡先と場所
研究連絡先
研究連絡先
- 名前:Suxia Li
- 電話番号:+86 158 5410 7085
- メール:lsuxiasusu@163.com
参加基準
適格基準
適格基準
就学可能な年齢
- 大人
- 高齢者
健康ボランティアの受け入れ
説明
Inclusion Criteria:
You must meet all the following inclusion criteria to participate in the study:
- Patients with corneal stromal defects, including those caused by trauma or following lesion excision for infection, with a residual stromal thickness of ≥300 μm in the defect area.
- Patients aged 18 to 85 years (inclusive, either sex) at the time of consent.
- Patients who are capable of providing written informed consent voluntarily to participate in the study.
Exclusion Criteria:
You will be excluded from the study if you meet any of the following exclusion criteria:
- Patients with unexplained keratoconjunctival diseases.
- Patients with severe dry eye, symblepharon, corneal neovascularization, or other ocular surface disorders.
- Patients with systemic infectious diseases (positive for bacteria/fungi/HBV/HCV/HIV/TP, etc.).
- Patients with autoimmune diseases such as rheumatoid arthritis, Sjögren's syndrome, or graft-versus-host disease.
- Patients with uncontrolled ocular diseases in the study eye.
- Patients with major organ failure or other serious systemic conditions, including but not limited to cardiac insufficiency; poorly controlled diabetes mellitus (fasting blood glucose >8 mmol/L despite glucose-lowering therapy); uncontrolled stage II or higher hypertension (blood pressure >160/100 mmHg despite antihypertensive therapy); history of malignancy within the past 5 years; severe immunodeficiency, etc.
- Patients with psychiatric disorders that may interfere with treatment or evaluation.
- Pregnant or lactating women, or women planning to become pregnant during the clinical study.
- Patients deemed unsuitable for participation in the clinical trial by the investigator.
- Patients unable to complete follow-up visits.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:なし
- 介入モデル:単一グループの割り当て
- マスキング:なし(オープンラベル)
アーム数
武器と介入
参加者グループ / アーム参加者グループ / アーム |
介入・治療介入・治療 |
|---|---|
|
実験的:Sutureless Ophthalmic Hydrogel for Repairing Corneal Stromal Defects
|
Surgery was performed under peribulbar block anesthesia.
After excision of the corneal lesion, the surface moisture of the recipient bed was dried with a sponge, and a cotton pad was placed over the pupillary area to protect the fundus.
The hydrogel was pre-liquefied in a 37 °C water bath, then instilled into the lamellar defect using a sterile syringe, followed by irradiation with a 365 nm light source at an intensity of 18 mW/cm² for 30 seconds to achieve curing.
A bandage contact lens could be applied.
|
この研究は何を測定していますか?
主要な結果の測定
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Incidence of Ocular Adverse Events and Hydrogel-Related Ocular Complications (Irritation, Displacement, Infection, Corneal Cell/Epithelial Changes)
時間枠:1st day, 1st week, 2nd week, 1st month and 2nd month postoperatively
|
Description: Assess ocular safety outcomes including:
|
1st day, 1st week, 2nd week, 1st month and 2nd month postoperatively
|
二次結果の測定
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Corneal Clarity Full Rating Scale (0-4 points full-scale assessment for corneal transparency after hydrogel repair)
時間枠:1st day, 1st week, 2nd week, 1st month and 2nd month postoperatively
|
Observe the transparency of the cornea in the hydrogel transplantation area using a slit lamp examination, score it, and record the corneal transparency scores at different follow-up time points. Full scale information: Minimum score = 0, Maximum score = 4; higher scores indicate worse corneal opacity/poorer corneal clarity, lower scores indicate better corneal transparency. Scoring criteria: 0 = completely transparent;
|
1st day, 1st week, 2nd week, 1st month and 2nd month postoperatively
|
|
Change in corneal thickness (OCT measurement, µm)
時間枠:1st day, 1st week, 2nd week, 1st month and 2nd month postoperatively
|
Use corneal OCT to observe changes in corneal thickness in the hydrogel transplantation area, and record the residual corneal thickness, hydrogel thickness, and total corneal thickness at different follow-up time points.
|
1st day, 1st week, 2nd week, 1st month and 2nd month postoperatively
|
|
Change in visual acuity (decimal chart)
時間枠:1st day preoperatively, 1st day, 1st week, 2nd week, 1st month and 2nd month postoperatively
|
Use a decimal visual acuity chart to record the visual acuity and best corrected visual acuity at different follow-up time points, and evaluate the recovery and changes in visual acuity
|
1st day preoperatively, 1st day, 1st week, 2nd week, 1st month and 2nd month postoperatively
|
協力者と研究者
研究記録日
主要日程の研究
研究開始 (推定)
研究開始
一次修了 (推定)
一次修了
研究の完了 (推定)
研究の完了
試験登録日
最初に提出
最初に提出
QC基準を満たした最初の提出物
QC基準を満たした最初の提出物
最初の投稿 (実際)
最初の投稿
学習記録の更新
投稿された最後の更新 (実際)
投稿された最後の更新
QC基準を満たした最後の更新が送信されました
QC基準を満たした最後の更新が送信されました
最終確認日
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
その他の研究ID番号
- SDSYKYY202510-2
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD 共有サポート情報タイプ
- STUDY_PROTOCOL
- SAP
- ICF
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。